ALPMF News and Press, Astellas Pharma Inc

2024-07-15 12:03:52 ET More on Lexeo Therapeutics Lexeo Therapeutics reports Q1 results IPO Roundup: Viking Holdings, RanMarine Technology, and more Historical earnings data for Lexeo Therapeutics Financial information for Lexeo Therapeutics Read th...

2024-06-01 17:52:36 ET More on Corbus Pharmaceuticals Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology Corbus Pharmaceuticals a new outperform at RBC on cancer, obesity assets Seeking Alpha’s Quant Rating on Corbus Pharmaceutical...

2024-05-31 13:04:02 ET More on Astellas Pharma Astellas Pharma Inc. (ALPMF) Q4 2023 Earnings Call Transcript Astellas Pharma partners with YASKAWA for innovative cell therapy Astellas Pharma Non-GAAP EPS of ¥84.19, revenue of ¥1603.67B; initiates FY24 guida...

2024-05-21 06:38:46 ET More on Astellas Pharma Astellas Pharma Non-GAAP EPS of ¥84.19, revenue of ¥1603.67B; initiates FY24 guidance Pfizer, Astellas first-line bladder cancer therapy accepted for review in China Seeking Alpha’s Quant Rating on Astel...

2024-05-13 13:24:17 ET More on Corbus Pharmaceuticals Neutral On Corbus Pharmaceuticals' Financials And Clinical Progress In Oncology Seeking Alpha’s Quant Rating on Corbus Pharmaceuticals Historical earnings data for Corbus Pharmaceuticals Financial i...

2024-05-02 15:32:05 ET Summary CytomX Therapeutics, Inc. results from phase 1a dose-escalation study, using CX-904 for the treatment of patients with EGFR expressing solid tumors, expected with Q1 2024 earnings on May 8, 2024. Pending positive data, plus at the discretion of partn...

2024-05-01 13:54:38 ET Poseida Therapeutics ( NASDAQ: PSTX ) shares traded higher on Wednesday after the company and Japanese drugmaker Astellas ( OTCPK:ALPMY ) announced a partnership to develop and commercialize CAR-T cell therapies for cancer.... Read the full article o...

2024-04-26 18:00:03 ET Astellas Pharma Inc. (ALPMF) Q4 2023 Results Conference Call April 25, 2024 04:00 AM ET Company Participants Hiromitsu Ikeda - Chief Communications and Investor Relations Officer Naoki Okamura - President and Chief Executive Office Yoshitsu...

2024-04-25 03:54:46 ET More on Astellas Pharma: Pfizer, Astellas first-line bladder cancer therapy accepted for review in China Astellas collaborates with Mass General Brigham for translational medicine Historical earnings data for Astellas Pharma Read the ...

2024-04-24 11:12:04 ET Major earnings expected before the bell on Thursday include: Bristol-Myers Squibb ( BMY ) Caterpillar ( CAT ) Comcast ( CMCSA ) Altria Group ( MO ) Merck & Co ( MRK ) Read the full article on Seeking Alpha Fo...